ALCAM and lobular neoplasia: In Figure 1A, the comparative graph for ALCAM reveals a statistically significant elevation in SLE without LN (2,601.4 ± 2,826.4 pg/ml) and LN patients (10,685.3 ± 14,488.5 pg/ml) compared to HCs (1,192.6 ± 577.0 pg/ml).